Meinian Onehealth Healthcare Holdings (SZSE:002044) Shareholders Have Endured a 57% Loss From Investing in the Stock Five Years Ago
Meinian Onehealth Healthcare Holdings (SZSE:002044) Shareholders Have Endured a 57% Loss From Investing in the Stock Five Years Ago
We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. Zooming in on an example, the Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) share price dropped 57% in the last half decade. We certainly feel for shareholders who bought near the top.
我们认为明智的长期投资是必经之路。但不幸的是,有些公司根本没有成功。举个例子,美年Onehealth医疗控股有限公司(SZSE:002044)的股价在过去五年中下跌了57%。对于那些买入接近顶部的股东,我们当然有同感。
Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.
由于从长远来看,股东会下跌,让我们来看看那段时间的潜在基本面,看看它们与回报是否一致。
View our latest analysis for Meinian Onehealth Healthcare Holdings
查看我们对美年康健医疗控股的最新分析
We don't think that Meinian Onehealth Healthcare Holdings' modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. As a general rule, we think this kind of company is more comparable to loss-making stocks, since the actual profit is so low. For shareholders to have confidence a company will grow profits significantly, it must grow revenue.
我们认为,美尼安Onehealth Healthcare Holdings过去十二个月的微薄利润目前并未引起市场的充分关注。我们认为收入可能是更好的指南。一般而言,我们认为这种公司更能与亏损股票相提并论,因为实际利润太低了。为了让股东有信心公司大幅增加利润,它必须增加收入。
In the last half decade, Meinian Onehealth Healthcare Holdings saw its revenue increase by 3.7% per year. That's not a very high growth rate considering it doesn't make profits. It's likely this weak growth has contributed to an annualised return of 9% for the last five years. We want to see an acceleration of revenue growth (or profits) before showing much interest in this one. However, it's possible too many in the market will ignore it, and there may be an opportunity if it starts to recover down the track.
在过去的五年中,美年Onehealth Healthcare Holdings的收入每年增长3.7%。考虑到它不赚钱,这并不是一个很高的增长率。在过去五年中,这种疲软的增长很可能导致年化回报率为9%。在对此表现出浓厚兴趣之前,我们希望看到收入(或利润)的加速。但是,市场上可能有太多人会忽视它,如果它开始走上正轨,可能会有机会。
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
下图描述了收入和收入随时间推移而发生的变化(点击图片即可显示确切的数值)。
We know that Meinian Onehealth Healthcare Holdings has improved its bottom line lately, but what does the future have in store? You can see what analysts are predicting for Meinian Onehealth Healthcare Holdings in this interactive graph of future profit estimates.
我们知道美年Onehealth Healthcare Holdings最近提高了利润,但是未来会发生什么?在这张未来利润估计的交互式图表中,你可以看到分析师对美年Onehealth Healthcare Holdings的预测。
A Different Perspective
不同的视角
We're pleased to report that Meinian Onehealth Healthcare Holdings shareholders have received a total shareholder return of 3.7% over one year. Of course, that includes the dividend. Notably the five-year annualised TSR loss of 9% per year compares very unfavourably with the recent share price performance. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a (positive) inflection point within the business. It's always interesting to track share price performance over the longer term. But to understand Meinian Onehealth Healthcare Holdings better, we need to consider many other factors. To that end, you should be aware of the 1 warning sign we've spotted with Meinian Onehealth Healthcare Holdings .
我们很高兴地向大家报告,美年Onehealth Healthcare Holdings的股东在一年内获得了3.7%的股东总回报率。当然,这包括分红。值得注意的是,五年期年化股东总回报率每年亏损9%,与最近的股价表现相比非常不利。我们通常更看重短期内的长期业绩,但最近的改善可能暗示业务将出现(积极的)转折点。长期跟踪股价表现总是很有意思的。但是,为了更好地了解美年Onehealth Healthcare Holdings,我们需要考虑许多其他因素。为此,你应该注意我们在Meinian Onehealth Healthcare Holdings发现的1个警告信号。
We will like Meinian Onehealth Healthcare Holdings better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
如果我们看到一些大规模的内幕收购,我们会更喜欢美年Onehealth Healthcare Holdings。在我们等待的同时,请查看这份免费名单,列出了最近有大量内幕买入的成长型公司。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。